This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Patient-Physician Relationship/ Care  • Patient-Physician Communication  • End-of-life Care/ Palliative Medicine  • Patient Education/ Health Literacy  • Cardiovascular System  • Prognosis/ Outcomes  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Clyde W. Yancy, MD

JAMA. 2008;299(21):2566-2567.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of JAMA, Allen and colleagues¹ report findings from a provocative study that identifies a disconnection between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. In so doing, this study provides challenges to evaluating the need to know prognosis, communicating prognostic information, and anticipating the consequences of such information for a patient with heart failure.

Allen et al used the Seattle Heart Failure Model (SHFM)² to estimate life expectancy in the setting of stable ambulatory chronic heart failure in a small single-center tertiary care patient population and then determined the actuarial-predicted life expectancy in the absence of any known disease. To determine the patient's own assessment of survival, a de novo questionnaire was constructed to determine life traits and perceptions, with the scores acquired using a visual analog scale. Questions to assess depression (using a modified Beck Depression Inventory) and . . . [Full Text of this Article]

Author Affiliation: Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Patient-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure—Reply
Larry A. Allen, Jonathan E. Yager, and G. Michael Felker
JAMA. 2008;300(18):2117.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure
Larry A. Allen, Jonathan E. Yager, Michele Jonsson Funk, Wayne C. Levy, James A. Tulsky, Margaret T. Bowers, Gwen C. Dodson, Christopher M. O’Connor, and G. Michael Felker
JAMA. 2008;299(21):2533-2542.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
Wedel et al.
Eur J Heart Fail 2009;11:281-291.
ABSTRACT | FULL TEXT  

Patient-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure--Reply
Allen et al.
JAMA 2008;300:2117-2117.
FULL TEXT  

How Accurately Do Patients with Heart Failure Predict Life Expectancy?
JWatch General 2008;2008:3-3.
FULL TEXT